Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.

doi:10.1200/JCO.2021.39.15_suppl.e15554

HFCAS OpenIR

	Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.
	Yuan, Ying ; Fu, Xianhua ; Ying, Jieer ; Yang, Liu ; Fang, Weijia ; Han, Weidong ; Zhang, Suzhan
	2021-05-20
发表期刊	JOURNAL OF CLINICAL ONCOLOGY
ISSN	0732-183X
DOI	10.1200/JCO.2021.39.15_suppl.e15554
收录类别	SCI
语种	英语
资助项目	Jiangsu Hengrui Pharmaceuticals Co., Ltd
项目资助者	Jiangsu Hengrui Pharmaceuticals Co., Ltd
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000708120301219
出版者	LIPPINCOTT WILLIAMS & WILKINS
引用统计	被引频次：8[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/126589
专题	中国科学院合肥物质科学研究院
作者单位	1.Zhejiang Univ, Affiliated Hosp 2, Dept Med Oncol, Sch Med, Hangzhou, Zhejiang, Peoples R China 2.Chinese Acad Sci, Zhejiang Canc Hosp, Inst Canc & Basic Med IBMC, Canc Hosp, Hangzhou, Zhejiang, Peoples R China 3.Peoples Hosp Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China 4.Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Sch Med, Hangzhou, Peoples R China 5.Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Med Oncol, Sch Med, Hangzhou, Zhejiang, Peoples R China 6.Zhejiang Univ, Affiliated Hosp 2, China Natl Minist Educ, Canc Inst Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China 7.Zhejiang Univ, Affiliated Hosp 2, Dept Colorectal Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China
推荐引用方式 GB/T 7714	Yuan, Ying,Fu, Xianhua,Ying, Jieer,et al. Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39.
APA	Yuan, Ying.,Fu, Xianhua.,Ying, Jieer.,Yang, Liu.,Fang, Weijia.,...&Zhang, Suzhan.(2021).Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial..JOURNAL OF CLINICAL ONCOLOGY,39.
MLA	Yuan, Ying,et al."Dual-targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: Preliminary results from a multicenter phase 2 trial.".JOURNAL OF CLINICAL ONCOLOGY 39(2021).